  Glycoprotein biomarkers for the early detection of aggressive prostate cancer  
Specific glycoproteins and glycan modifications of glycoproteins might be used to distinguish aggressive and non-aggressive prostate cancer in tissue and serum. Development of novel glycoprotein biomarkers for tissue and serum tests that can detect aggressive cancer. 
NIH Project. The Early Detection Research Network: Biomarker Developmental Laboratories. PI: Hui Zhang, PhD, Assistant Professor of the Department of Pathology at the John Hopkins University.